Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
188
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder – expert consensus survey part 2

Martha Sajatovic1 Department of Psychiatry, University Hospitals Cleveland Medical Center, Cleveland, OH, USA;2 Departments of Psychiatry and Neurology, Case Western Reserve University School of Medicine, Cleveland, OH, USACorrespondence[email protected]
,
Ruth Ross3 Ross Editorial, Port Townsend, WA, USA
,
Susan N Legacy4 US Medical Affairs Neuroscience, Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ, USA
,
Matthew Byerly5 Cell Biology and Neuroscience, Center for Mental Health Research and Recovery, Montana State University, Bozeman, MT, USA
,
John M Kane6 Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA;7 Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Glen Oaks, NY, USA
,
Faith DiBiasi8 Scientific Communications, Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD, USA
,
Heather Fitzgerald9 Medical Affairs, Lundbeck LLC, Deerfield, IL, USA
&
Christoph U Correll6 Psychiatry, The Zucker Hillside Hospital, Glen Oaks, NY, USA;7 Psychiatry, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Glen Oaks, NY, USA
 show all
Pages 1475-1492 | Published online: 08 Jun 2018

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

John FP Bridges, Joseph F Goldberg, Heather M Fitzgerald, Sanjeda R Chumki, Kathleen Beusterien, Oliver Will & Leslie Citrome. (2023) Prioritizing Treatment Goals of People Diagnosed with Bipolar I Disorder in the US: Best–Worst Scaling Results. Patient Preference and Adherence 17, pages 2545-2555.
Read now
Ruth Milz, Carmela Benson, Karl Knight, Jose Antunes, Dean Najarian, Paola-Maria Lopez Rengel, Steven Wang, Ute Richarz, Srihari Gopal & John M Kane. (2023) The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia. Neuropsychiatric Disease and Treatment 19, pages 531-545.
Read now
Mikkel Højlund & Christoph U. Correll. (2023) Switching to long-acting injectable antipsychotics: pharmacological considerations and practical approaches. Expert Opinion on Pharmacotherapy 24:13, pages 1463-1489.
Read now
Peter M. Haddad & Christoph U. Correll. (2023) Long-acting antipsychotics in the treatment of schizophrenia: opportunities and challenges. Expert Opinion on Pharmacotherapy 24:4, pages 473-493.
Read now
Renato de Filippis, Pasquale De Fazio, Raffaele Gaetano, Luca Steardo, Clemente Cedro, Antonio Bruno, Rocco Antonio Zoccali & Maria Rosaria Anna Muscatello. (2021) Current and emerging long-acting antipsychotics for the treatment of schizophrenia. Expert Opinion on Drug Safety 20:7, pages 771-790.
Read now

Articles from other publishers (14)

Blake R. EricksonJarrod EhrieSamuel MurrayRyan J. DoughertyMilton L. WainbergLisa B. DixonMatthew L. Goldman. (2023) A Rapid Review of “Low-Threshold” Psychiatric Medication Prescribing: Considerations for Street Medicine and Beyond. Psychiatric Services 74:3, pages 282-291.
Crossref
Christoph U. Correll, Craig Chepke, Paul Gionfriddo, Joe Parks, Phyllis Foxworth, Anirban Basu, Teri S. Brister, Dawn Brown, Christopher Clarke & Youssef Hassoun. (2022) The post COVID-19 healthcare landscape and the use of long-acting injectable antipsychotics for individuals with schizophrenia and bipolar I disorder: the importance of an integrated collaborative-care approach. BMC Psychiatry 22:1.
Crossref
Roger W. Sommi, Bhaskar Rege, Angela Wehr, Sejal Faldu, Yangchun Du & Peter J. Weiden. (2020) Aripiprazole Lauroxil Dosing Regimens: Understanding Dosage Strengths and Injection Intervals. CNS Spectrums 27:3, pages 262-267.
Crossref
Lisa Lewis & Jill Rodgers. (2022) Development and Evaluation of a Web-Based Educational Toolkit on the Knowledge, Attitudes, and Practices of Psychiatric Prescribers Regarding Long-Acting Injectable Antipsychotics. Journal of the American Psychiatric Nurses Association 28:2, pages 117-127.
Crossref
Petru Ifteni, Paula-Simina Petric & Andreea Teodorescu. (2021) Rating Opportunity for Long-Acting Injectable Antipsychotic Initiation Index (ROLIN). Frontiers in Psychiatry 12.
Crossref
John M. Kane, Joseph P. McEvoy, Christoph U. Correll & Pierre-Michel Llorca. (2021) Controversies Surrounding the Use of Long-Acting Injectable Antipsychotic Medications for the Treatment of Patients with Schizophrenia. CNS Drugs 35:11, pages 1189-1205.
Crossref
Daniel Guinart, Heidi Taipale, Jose M Rubio, Antti Tanskanen, Christoph U Correll, Jari Tiihonen & John M Kane. (2021) Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort. Schizophrenia Bulletin 47:6, pages 1621-1630.
Crossref
Lorenzo Tatini, Giulio D’Anna, Francesco Pietrini, Eugenia Calligaris, Andrea Ballerini & Valdo Ricca. (2021) Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10. International Clinical Psychopharmacology 36:4, pages 181-187.
Crossref
Amal Abdel‐Baki, Dominic Thibault, Sofia Medrano, Emmanuel Stip, Martin Ladouceur, Ramzan Tahir & Stephane Potvin. (2019) Long‐acting antipsychotic medication as first‐line treatment of first‐episode psychosis with comorbid substance use disorder. Early Intervention in Psychiatry 14:1, pages 69-79.
Crossref
Emmanuel Stip, Syed Javaid, Jonathan Bayard-Diotte, Karim Abdel Aziz & Danilo Arnone. (2020) Use of long acting antipsychotics and relationship to newly diagnosed bipolar disorder: a pragmatic longitudinal study based on a Canadian health registry. Therapeutic Advances in Psychopharmacology 10, pages 204512532095711.
Crossref
Robert Cowan, Joshua M. Cohen, Erik Rosenman & Ravi Iyer. (2019) Physician and patient preferences for dosing options in migraine prevention. The Journal of Headache and Pain 20:1.
Crossref
Luisa Peters, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, Viktor B. Nöhles & Christoph U. Correll. (2019) Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016–March 2019. Current Psychiatry Reports 21:12.
Crossref
Libor Ustohal. (2019) Maintenance treatment of schizophrenia with long‑acting injectable antipsychotics - work with patients and their family members. Psychiatrie pro praxi 20:1, pages 12-16.
Crossref
Qian Cai, Charmi Patel, Edward Kim, Nancy Connolly, Ozgur Tunceli & Antoine C. El Khoury. (2019) Factors Associated with the Initiation of Long-Acting Injectable Paliperidone Palmitate Versus Aripiprazole Among Medicaid Patients with Schizophrenia: An Observational Study. Advances in Therapy 36:4, pages 858-869.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.